What is known about letermovir passing into human breast milk and the risk to breastfed infants?

Whether letermovir passes into human milk is unknown, although animal data show milk excretion; risk to newborns/infants cannot be excluded, so a decision to discontinue breastfeeding or discontinue/abstain from letermovir must weigh breastfeeding benefits for the child against treatment benefits for the woman.